Table 6.

Correlation analysis of BP-related indicators (r/p).

	IL-17	IL-18	IL-22	IL-25	EOS	BP180	BP230	IgE
IL-17	–	0.238 (p = 0.064)	0.661 (p < 0.001)	0.758 (p < 0.001)	0.070 (p = 0.592)	0.272 (p = 0.035)	0.059 (p = 0.653)	0.026 (p = 0.876)
IL-18	0.238 (p = 0.064)	–	0.329 (p = 0.010)	0.182 (p = 0.160)	−0.227 (p = 0.078)	0.167 (p = 0.203)	0.001 (p = 0.996)	0.249 (p = 0.122)
IL-22	0.661 (p < 0.001)	0.329 (p = 0.010)	–	0.684 (p < 0.001)	0.191 (p = 0.141)	0.176 (p = 0.179)	0.107 (p = 0.414)	0.110 (p = 0.498)
IL-25	0.758 (p < 0.001)	0.182 (p = 0.160)	0.684 (p < 0.001)	–	0.131 (p = 0.316)	0.076 (p = 0.564)	0.102 (p = 0.439)	−0.093 (p = 0.567)
EOS	0.070 (p = 0.592)	−0.227 (p = 0.078)	0.191 (p = 0.141)	0.131 (p = 0.316)	–	0.311 (p = 0.016)	0.105 (p = 0.423)	0.193 (p = 0.233)
BP180	0.272 (p = 0.035)	0.167 (p = 0.203)	0.176 (p = 0.179)	0.076 (p = 0.564)	0.311 (p = 0.016)	–	0.099 (p = 0.451)	0.136 (p = 0.408)
BP230	0.059 (p = 0.653)	0.001 (p = 0.996)	0.107 (p = 0.414)	0.102 (p = 0.439)	0.105 (p = 0.423)	0.099 (p = 0.451)	–	0.293 (p = 0.070)
IgE	0.026 (p = 0.876)	0.249 (p = 0.122)	0.110 (p = 0.498)	−0.093 (p = 0.567)	0.193 (p = 0.233)	0.136 (p = 0.408)	0.293 (p = 0.070)	–